InvestorsHub Logo
Followers 55
Posts 2608
Boards Moderated 0
Alias Born 02/04/2014

Re: Deborah1 post# 32803

Tuesday, 03/17/2015 4:41:30 PM

Tuesday, March 17, 2015 4:41:30 PM

Post# of 144814
Here is a video clip of Dr Von Hoff. Truly an amazing man.. We are blessed that he was intersted in Cell in a Box(R) technology. And we are hopeful the blessing will be passed on to others in need.



"The Nuvilex team presents us with a new tool to employ against the symptoms and invasive properties of this very challenging cancer," said Daniel D. Von Hoff, M.D., Chief Development Officer of TD2. "Our Pancreatic Cancer Research Team (PCRT) colleagues are enthusiastic to begin clinical trials with this approach."

http://www.td2inc.com/news/nuvilex-selects-translational-drug-development-td2-to-advanc


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News